Trials / Completed
CompletedNCT05995366
A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose Administration
Mass Balance Study of [14C] ABBV-903 in Healthy Male Subjects Following Single Oral Dose Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the mass balance and safety of \[14C\] ABBV-903 in healthy male volunteers following a single oral dose administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABBV-903 | Solution; Oral |
Timeline
- Start date
- 2023-08-18
- Primary completion
- 2023-10-13
- Completion
- 2023-10-13
- First posted
- 2023-08-16
- Last updated
- 2023-10-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05995366. Inclusion in this directory is not an endorsement.